Bioabsorbable Therapeutics logo

Bioabsorbable Therapeutics

Innovative solutions for coronary and peripheral vascular treatments with cutting-edge bioabsorbable stent systems.

est. 2004

VS
Svelte Medical Systems logo

Svelte Medical Systems

Advancing coronary care with innovative, highly deliverable stent solutions designed for safety and efficiency.

est. 2007

Bioabsorbable Therapeutics is the older company (2004 vs 2007).

Side-by-Side Comparison

Bioabsorbable Therapeutics Svelte Medical Systems
Founded
2004 older 2007
Headquarters
Not tracked yet Not tracked yet
Employees
Not tracked yet Not tracked yet
Industry
Biotechnology, Health Care, Medical Devices Health Care, Medical Devices
Funding Stage
Debt Financing Series Unknown
Total Funding
$9.36M $128.41M
Funding Rounds
2 11
Services
Not tracked yet Not tracked yet
Target Customers
Not tracked yet Not tracked yet
Taxonomy
Bioabsorbable Stents, Medical Devices, Vascular Treatment, Coronary Stents, Peripheral Stents, Anti-inflammatory Polymers, Cardiovascular Medicine, Innovative Healthcare Solutions, Menlo Park, Medical Technology, Start-up Company, Bioabsorbable Coatings, Innovative Therapies Coronary Stent Market, Stent Deliverability, Balloon-Expandable Stent, Drug-Eluting Stent, Non-Thrombogenic Technology, Non-Inflammatory Technology, Medical Device Innovation, Clinical Safety Enhancement, Cost Reduction In Medical Devices, Privately Held Medical Company, Cardiovascular Healthcare, Biomedical Engineering, Interventional Cardiology
Website
bioabsorbabletx.com sveltemedical.com
Bioabsorbable Therapeutics logo

About Bioabsorbable Therapeutics

**Bioabsorbable Therapeutics** Bioabsorbable Therapeutics specializes in the creation and distribution of medical devices for coronary and peripheral vascular disease treatment. Their product lineup includes the Whisper coronary stent system, a balloon-expandable fully absorbable coronary stent, and...

Svelte Medical Systems logo

About Svelte Medical Systems

Svelte Medical Systems, founded in 2007 by Robert Fischell, David Fischell, and Tim Fischell, is positioned within the burgeoning $5 billion coronary stent market. Operating in the Health Care and Medical Devices sectors, the company aims to revolutionize coronary care with its innovative stent solu...

We will tell you when either one moves

BounceWatch watches Bioabsorbable Therapeutics and Svelte Medical Systems for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Bioabsorbable Therapeu... and Svelte Medical Systems — by email.

Frequently Asked Questions

Bioabsorbable Therapeutics — Innovative solutions for coronary and peripheral vascular treatments with cutting-edge bioabsorbable stent systems.. Svelte Medical Systems — Advancing coronary care with innovative, highly deliverable stent solutions designed for safety and efficiency.. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Bioabsorbable Therapeutics has raised $9.36M while Svelte Medical Systems has raised $128.41M.
Bioabsorbable Therapeutics and Svelte Medical Systems operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Bioabsorbable Therapeutics with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Bioabsorbable Therapeutics on 25 Jul 2024, and Svelte Medical Systems on 22 Mar 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes